Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Leukemia 2Vomiting 1Sarcoma, Synovial 1Sarcoma, Ewing 1Rhabdoid Tumor 1Recurrence 1PRETEXT I Hepatoblastoma 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Nausea 1Lymphoma, Large-Cell, Anaplastic 1Localized Extraskeletal Ewing Sarcoma 1Liposarcoma 1Leiomyosarcoma 1Hypersensitivity 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Ganglioneuroblastoma 1Fibrosarcoma 1Extravasations of Anthracycline Anti-cancer Agents 1Drug-Related Side Effects and Adverse Reactions 1Dermatofibrosarcoma 1Degradation of Top2b and Top2a in Human by Dexrazoxane 1Central Nervous System Neoplasms 1

Interventions

pazopanib 4Doxorubicin 4Sirolimus 3Ifosfamide 3Sorafenib 2Radiotherapy 2Etoposide 2thymoglobulin 1temsirolimus 1tazemetostat 1sapanisertib 1romidepsin 1pexidartinib 1lorvotuzumab mertansine 1liposomal doxorubicin 1indolepropanol phosphate 1fludarabine phosphate 1Watchful Waiting 1Thiotepa 1Tacrolimus 1Sunitinib 1Stem Cell Transplantation 1STA 9090 1Razoxane 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Polymerase Chain Reaction 1Observation 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neurofibrosarcoma × Dexrazoxane × Clear all
NCT02584309 2023-11-07

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

Washington University School of Medicine

Phase 2 Completed
73 enrolled 11 charts
Sarcoma

Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡